Latest articles from Renal and Urology News The Medical Minute episodes:

• January 30, 2014New Link Between Exercise, PCa Found in Blood Vessels

  Researchers found that PCa patients who walked at a faster pace were more likely to have healthier blood vessels.

  ...more

  

  ---

• January 28, 2014Melatonin Levels Affect Prostate Cancer Risk

  Researchers conducted a study in Iceland that found an association between prostate cancer risk and quality of sleep.

  ...more

  

  ---

• January 17, 2014Geographic Differences for Children on Donor Waitlist

  A new study is suggesting there is substantial geographic variation in deceased donor kidney waiting times.

  ...more

  

  ---

• January 15, 2014New Tool Predicts Prostate Cancer Overdiagnosis

  Researchers have developed a personalized tool that can predict the likelihood of prostate cancer overdiagnosis.

  ...more

  

  ---

• January 13, 2014Novel Antibody Under Development for Type 1 Diabetes

  A new product known as BL-9020 is being developed by Israeli researchers.

  ...more

  

  ---

• December 26, 2013Low-Fat Diet, Coffee Appear to Improve PCa Outcomes

  This year, several studies have suggested some foods and beverages may be highly beneficial to men with prostate cancer.

  ...more

  

  ---

• December 24, 2013Chemical in Dialyzers May Be Toxic to Immune Cells

  Levels of bisphenol A in components of dialysis machines may be toxic to immune cells circulating in hemodialysis patients.

  ...more

  

  ---

• December 20, 2013Investigational Drug May Boost Survival in Men with Metastatic PCa

  An investigational new agent called tasquinimod may help increase survival in men with metastatic prostate cancer.

  ...more

  

  ---

• December 18, 2013Primary CKD Screening in the General Population Not Cost-Effective

  A new systematic literature review has found that it may not be cost-effective to provide primary screening for CKD in the general population.

  ...more

  

  ---

• December 16, 2013Experimental Agent Shows Promise for Peyronie's Disease

  Phase 3 studies assessing XIAFLEX show this agent may significantly improve quality of life.

  ...more

  

  ---